• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.

作者信息

Sellner Leopold, Schetelig Johannes, Koster Linda, Choi Goda, Blaise Didier, Beelen Dietrich, Schianca Fabrizio Carnevale, Passweg Jakob, Schanz Urs, Gyan Emmanuel, Sora Federica, Kröger Nicolaus, Wulf Gerald G, Van Gorkom Gwendolyn, Mayer Jiri, Orvain Corentin, Bourhis Jean Henri, Jindra Pavel, Potter Victoria, Zallio Francesco, Vandenberghe Elisabeth, Robinson Stephen, Hayden Patrick J, Yakoub-Agha Ibrahim, Montoto Silvia, Dreger Peter

机构信息

University Hospital Heidelberg, Heidelberg, Germany.

Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.

出版信息

Bone Marrow Transplant. 2020 Dec;55(12):2335-2338. doi: 10.1038/s41409-020-0946-x. Epub 2020 May 22.

DOI:10.1038/s41409-020-0946-x
PMID:
32444863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497266/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e95/8497266/88cf58035637/41409_2020_946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e95/8497266/88cf58035637/41409_2020_946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e95/8497266/88cf58035637/41409_2020_946_Fig1_HTML.jpg

相似文献

1
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.滤泡性淋巴瘤患者异基因干细胞移植前的idelalisib暴露情况：一项欧洲血液与骨髓移植协会（EBMT）的调查。
Bone Marrow Transplant. 2020 Dec;55(12):2335-2338. doi: 10.1038/s41409-020-0946-x. Epub 2020 May 22.
2
Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report.idelalisib作为复发滤泡性淋巴瘤异基因干细胞移植桥梁的疗效：病例报告
Tumori. 2017 Nov 15;103(Suppl. 1):e41-e43. doi: 10.5301/tj.5000679.
3
Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report.idelalisib作为复发/难治性淋巴瘤合并肾癌患者异基因移植的桥梁：一例报告
Clin Lymphoma Myeloma Leuk. 2020 Jan;20(1):e15-e17. doi: 10.1016/j.clml.2019.10.008. Epub 2019 Oct 21.
4
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.伊布替尼在慢性淋巴细胞白血病患者异基因造血干细胞移植前的治疗：欧洲血液与骨髓移植协会慢性恶性肿瘤工作组的报告
Bone Marrow Transplant. 2021 Mar;56(3):605-613. doi: 10.1038/s41409-020-01069-w. Epub 2020 Oct 2.
5
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.异基因造血干细胞移植治疗复发性滤泡淋巴瘤：代表 EBMT 淋巴瘤工作组和 CIBMTR 淋巴瘤委员会的联合分析。
Cancer. 2018 Apr 15;124(8):1733-1742. doi: 10.1002/cncr.31264. Epub 2018 Feb 9.
6
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.idelalisib、来那度胺和利妥昔单抗在复发难治性淋巴瘤中的安全性和耐受性：肿瘤临床试验联盟A051201和A051202 1期试验
Lancet Haematol. 2017 Apr;4(4):e176-e182. doi: 10.1016/S2352-3026(17)30028-5. Epub 2017 Mar 15.
7
Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.评估idelalisib 治疗复发/难治性滤泡性淋巴瘤和慢性淋巴细胞白血病日本患者的安全性和耐受性的 1b 期研究。
Jpn J Clin Oncol. 2020 Dec 16;50(12):1395-1402. doi: 10.1093/jjco/hyaa153.
8
Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report.一名难治性滤泡性淋巴瘤患者接受idelalisib单药治疗时出现银屑病样皮疹的管理：病例报告
J Med Case Rep. 2020 Feb 24;14(1):35. doi: 10.1186/s13256-020-2344-9.
9
Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?异基因干细胞移植治疗转化型滤泡性淋巴瘤属于抗淋巴瘤干细胞治疗吗？
Leuk Lymphoma. 2008 Oct;49(10):1852-3. doi: 10.1080/10428190802491714.
10
Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.减低强度预处理 HLA 相合同胞供者异基因造血干细胞移植治疗滤泡性淋巴瘤：来自两项前瞻性多中心研究的长期随访。
Haematologica. 2010 Jul;95(7):1176-82. doi: 10.3324/haematol.2009.017608. Epub 2010 Jan 27.

引用本文的文献

1
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.idelalisib治疗复发或难治性滤泡性淋巴瘤患者：意大利多中心观察性FolIdela研究
Cancers (Basel). 2022 Jan 27;14(3):654. doi: 10.3390/cancers14030654.

本文引用的文献

1
Effect of month and stallion on seminal characteristics and sexual behavior.月份和种马对精液特征及性行为的影响。
J Anim Sci. 1970 Oct;31(4):713-28. doi: 10.2527/jas1970.314713x.
2
[Antiepileptics].[抗癫痫药]
Mitt Dtsch Pharm Ges Pharm Ges DDR. 1969 Apr;39(4):73-87.
3
Oxidation of several aromatic hydrocarbons using dimethyl sulfoxide exposed to the atmosphere.使用暴露于大气中的二甲基亚砜对几种芳烃进行氧化。
Biochem Biophys Res Commun. 1971 Aug 6;44(3):521-5. doi: 10.1016/s0006-291x(71)80113-4.
4
Human placental lactogen and human pituitary prolactin.人胎盘催乳素和人垂体催乳素。
Clin Obstet Gynecol. 1971 Sep;14(3):669-84. doi: 10.1097/00003081-197109000-00003.
5
An attempt to inhibit the uterine luteolysin in the guinea-pig.抑制豚鼠子宫溶黄体素的尝试。
J Physiol. 1972 Apr;222(2):169P-170P.
6
Observations on the presence of immunity in rats to Angiostrongylus cantonensis (Chen).关于大鼠对广州管圆线虫（陈）免疫情况的观察。
Med J Malaya. 1965 Sep;20(1):70.
7
[Results of operative therapy of double kidney].[双侧肾脏手术治疗结果]
Urologe A. 1985 Mar;24(2):87-93.
8
Isolation, biochemical analysis, and N-terminal amino acid sequence of a cell surface glycoprotein that binds to the "erythrocyte receptor" of T-lymphocytes.与T淋巴细胞“红细胞受体”结合的细胞表面糖蛋白的分离、生化分析及N端氨基酸序列
Haematol Blood Transfus. 1987;31:337-40. doi: 10.1007/978-3-642-72624-8_70.